An AI startup company and its former chief executive officer have settled charges that they misrepresented projected revenue, according to the SEC.
Genesis
Posted inRegulatory Enforcement
Edwards Lifesciences pays $10M and creates antitrust compliance program under FTC judgment
Edwards Lifesciences Corp. will pay a $10 million penalty and create and maintain an antitrust compliance program under a pending agreement with the FTC for failing to notify the commission about its acquisition of JC Medical from Genesis MedTech Group.
